SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-16-518204
Filing Date
2016-03-25
Accepted
2016-03-25 16:26:07
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d169649d424b5.htm 424B5 228625
2 GRAPHIC g169649g18t21.jpg GRAPHIC 24310
3 GRAPHIC g169649g31a22.jpg GRAPHIC 22177
4 GRAPHIC g169649g54c50.jpg GRAPHIC 29062
5 GRAPHIC g169649g62y63.jpg GRAPHIC 22794
6 GRAPHIC g169649g96u84.jpg GRAPHIC 29668
  Complete submission text file 0001193125-16-518204.txt   406779
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-208314 | Film No.: 161529921
SIC: 2834 Pharmaceutical Preparations